Search results

Horizon Scanning 2025 Podcast Launch Series Hosted by our Director of Knowledge and Learning, Claire Marshall-Barrand, the launch series for 2025 offers five short episodes introducing this year’s major themes. Throughout the year, we’ll continue the conversation with in-depth episodes exploring em... ESG developments in 2025 Sustainability practitioners will be well aware that ESG is a fast-moving, and ever changing area, making keeping on top of developments a significant challenge. We have sought to set out key ESG developments expected in 2025, covering the UK and, at a hi... The Sustainability Omnibus – Streamlining Sustainability Regulation On 26 February 2025, the European Commission published its proposals for the first in a series of ‘omnibus’ packages, aimed at streamlining the EU’s sustainability and value chain due diligence legislation. The proposals hope to reduce sustainability... Reinventing the 9-5: a new way of working requires a new way of thinking Stub equity in UK take-privates: Practice Statement 36 on unlisted share alternatives The Energy Dividend: Power strategies to maximise data centre investments It’s no secret that in today’s digital age, defined by exponential growth in artificial intelligence, cloud computing, and other data-driven services, the major constraint on data centres is not computing capacity or network bandwidth, but the availabilit... Takeovers: Trends in 2025 Navigating the new cartel enforcement landscape Southwark Cathedral Map Slaughter and May is advising GlaxoSmithKline - agreement with Verily Life Sciences to form Galvani Bioelectronics Slaughter and May is advising GlaxoSmithKline plc on its agreement with Verily Life Sciences LLC (formerly Google Life Sciences), an Alphabet company, to form Galvani Bioelectronics.